New Accu-Chek Active goes on sale

Published: 2009-06-19 06:56:00

Updated: 2009-06-19 06:56:00

Roche Diagnostics Korea held its recent launching symposium of an updated version of Accu-Chek Active (model No. GC) at Plaza Hotel in Seoul.

The new Accu-Chek Active is a compact, convenient and precise device which allows diabetic patients who have to regularly monitor their PT/INR results t...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK